Management of malignancy-associated hypercalcemia

McCloskey E.V., Guest J.F., Kanis J.A., The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma, Drugs, 61, pp. 1253-1274, (2001)

Paterson A.H.G., Powles T.J., Kanis J.A., McCloskey E.V., Hanson J., Ashley S., Double-blind trial of oral clodronate in patients with bone metastases from breast cancer, J Clin Oncol, 11, pp. 59-65, (1993)

Diel I.J., Solomayer E.F., Costa S.D., Et al., Reduction in new metastases in breast cancer with adjuvant clodronate treatment, N Engl J Med, 339, pp. 357-363, (1998)

Van Holten-Verzantvoort A.T.M., Kroon H.M., Bijvoet O.L.M., Et al., Palliative pamidronate (APD) treatment in patients with bone metastases from breast cancer, J Clin Oncol, 11, pp. 491-498, (1993)

Hortobagyi G.N., Theriault R.L., Porter L., Et al., Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases, N Engl J Med, 335, pp. 1785-1791, (1996)

Hortobagyi G.N., Theriault R.L., Lipton A., Porter L., Blayney D., Sinoff C., Long-term prevention of skeletal complications of metastatic breast carcinoma with pamidronate, J Clin Oncol, 16, pp. 2038-2044, (1998)

Theriault R.L., Lipton A., Hortobagyi G.N., Et al., Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomised, placebo-controlled trial, J Clin Oncol, 17, pp. 846-855, (1999)

Hultborn R., Gundesen S., Ryden S., Et al., Efficacy of pamidronate in breast cancer with bone metastases: A randomised double-blind placebo-controlled multicenter study, Anticancer Res, 19, pp. 3383-3392, (1999)

Lahtinen R., Laakso M., Palva I., Et al., Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma, Lancet, 340, pp. 1049-1052, (1992)

Heim M.E., Clemens M.R., Queisser W., Et al., Prospective randomized trial of dichloromethylene bisphosphonate (clodronate) in patients with multiple myeloma requiring treatment: A multicentre study, Onkologie, 18, pp. 439-448, (1995)

McCloskey E.V., Guest J.F., Kanis J.A., The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma, Drugs, 61, pp. 1253-1274, (2001)

Paterson A.H.G., Powles T.J., Kanis J.A., McCloskey E.V., Hanson J., Ashley S., Double-blind trial of oral clodronate in patients with bone metastases from breast cancer, J Clin Oncol, 11, pp. 59-65, (1993)

Diel I.J., Solomayer E.F., Costa S.D., Et al., Reduction in new metastases in breast cancer with adjuvant clodronate treatment, N Engl J Med, 339, pp. 357-363, (1998)

Van Holten-Verzantvoort A.T.M., Kroon H.M., Bijvoet O.L.M., Et al., Palliative pamidronate (APD) treatment in patients with bone metastases from breast cancer, J Clin Oncol, 11, pp. 491-498, (1993)

Hortobagyi G.N., Theriault R.L., Porter L., Et al., Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases, N Engl J Med, 335, pp. 1785-1791, (1996)

Hortobagyi G.N., Theriault R.L., Lipton A., Porter L., Blayney D., Sinoff C., Long-term prevention of skeletal complications of metastatic breast carcinoma with pamidronate, J Clin Oncol, 16, pp. 2038-2044, (1998)

Theriault R.L., Lipton A., Hortobagyi G.N., Et al., Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomised, placebo-controlled trial, J Clin Oncol, 17, pp. 846-855, (1999)

Hultborn R., Gundesen S., Ryden S., Et al., Efficacy of pamidronate in breast cancer with bone metastases: A randomised double-blind placebo-controlled multicenter study, Anticancer Res, 19, pp. 3383-3392, (1999)

Lahtinen R., Laakso M., Palva I., Et al., Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma, Lancet, 340, pp. 1049-1052, (1992)

Heim M.E., Clemens M.R., Queisser W., Et al., Prospective randomized trial of dichloromethylene bisphosphonate (clodronate) in patients with multiple myeloma requiring treatment: A multicentre study, Onkologie, 18, pp. 439-448, (1995)